Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluzone (2008-2009) Immunogenicity and Safety in Adults
NCT00743275Phase 4Completed
- Sponsor
- Sanofi
- Start
- Aug 2008
- Primary completion
- Nov 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Fluzone Trivalent in influenza, sponsored by Sanofi. Primary endpoints: Number of Participants With at Least 1 Solicited Injection Site or Solicited Systemic Reaction, Geometric Mean Titers for the 3 Influenza Strains at Day 21 and 2 more. Started Aug 2008; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00743275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00743275.